1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Octapharma

Anonymous board for Octapharma


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    17
    Views:
    12,372
  2. Anonymous
    Replies:
    1
    Views:
    4,095
  3. Anonymous
    Replies:
    5
    Views:
    6,168
  4. Anonymous
    Replies:
    7
    Views:
    6,557
  5. Anonymous
    Replies:
    4
    Views:
    3,794
  6. Anonymous
    Replies:
    11
    Views:
    5,324
  7. Anonymous
    Replies:
    11
    Views:
    7,287
  8. Anonymous
    Replies:
    4
    Views:
    4,735
  9. Anonymous
    Replies:
    0
    Views:
    2,643
  10. Anonymous
    Replies:
    9
    Views:
    6,067
  11. Anonymous
    Replies:
    24
    Views:
    9,470
  12. Anonymous
    Replies:
    1
    Views:
    5,115
  13. Anonymous
    Replies:
    4
    Views:
    4,313
  14. Anonymous
    Replies:
    2
    Views:
    4,058
  15. Anonymous
    Replies:
    0
    Views:
    2,818
  16. Anonymous
    Replies:
    0
    Views:
    2,719
  17. Anonymous
    Replies:
    5
    Views:
    5,393
  18. Anonymous
    Replies:
    10
    Views:
    6,245
  19. Anonymous
    Replies:
    2
    Views:
    4,670
  20. Anonymous
    Replies:
    125
    Views:
    37,119

Thread Display Options

Loading...